Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin for implantation
ISRCTN67932311Phase 2Completed
- Sponsor
- University Hospitals Coventry and Warwickshire NHS Trust
- Start
- Sep 2016
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial in recurrent miscarriage (RPL) comparing Sitagliptin with Placebo (2 arms). Primary endpoint: Endometrial stromal cell clonogenicity. Started Sep 2016; status: completed.
02
Drugs
sitagliptin
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on ISRCTN67932311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN67932311.